webleads-tracker

Home  > MEDTECH
  > MEDTECH
 
  >  TOP STORY
“The acquisition of AWAIBA is a natural fit for CMOSIS. It strengthens our presence in existing markets and expands our activities in adjacent segments with complementary image sensor products. It also strengthens our relationship with our existing customer base,” stated Luc De Mey, ...


 
  >  PRESENTATION
Feel free to download Benjamin Roussel's presentation held at LOAC 2014 ... ...

 
  >  TRADE SHOWS & CONFERENCES
Bringing together researchers and industry participants from both academia and industry, this conference will discuss the innovative developments in Lab-on-a-Chip (LOAC), Microfluidics, and Microarrays Spaces. Presentations will explore the latest advances in LOAC, Microfluidics and Microarrays. Focus at this conference will also be given to some of the many applications of Lab-on-a-Chip, from ...
 
 
  >  LATEST REPORT
What strategies could new players use to enter the Point of Care market?...

 
  >  NEWS

The system will be used for clinical trials of targeted cancer therapies with a goal of...

Researchers at the University of California, San Diego have developed a sensor in the ...

The investment group led by HCM includes Shanghai Pudong Science ...

In their report published in Nature Materials, the investigators describe an stands for...

“The acquisition of AWAIBA is a natural fit for CMOSIS. It strengthens our ...

The winning abstract, “Versatile Electrical Platform for Accelerated Development ...

Described in a paper published online July 13 in Nature Medicine, the test employs ...

Innovative technology offers potential to transform eye care and further ...

It meets the needs of microfluidic applications that benefit from an advanced ...

PerkinElmer, Inc., a global leader focused on the health and safety of people and the ...

The hunt for a perfect contraceptive has gone on for millennia. A new candidate is now ...

In a move to accelerate the transformation of the healthcare industry, Royal Philips ...

Cepheid announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., ...

The alliance will initially focus on two key priorities: the development of drug-device...


©2007 Yole Developpement All rights reserved                  Disclaimer | Legal notice | To advertise
Yole Développement: Le Quartz, 75 cours Emile Zola, 69100 Villeurbanne, France. TEL: (33) 472 83 01 80 FAX: (33) 472 83 01 83 E-Mail: info @yole.fr